2,264 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Article Searches
Powell Industries (POWL) Is Up 7.48% in One Week: What You Should Know https://www.zacks.com/stock/news/2270774/powell-industries-powl-is-up-7-48-in-one-week-what-you-should-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_10-2270774 May 08, 2024 - Does Powell Industries (POWL) have what it takes to be a top stock pick for momentum investors? Let's find out.
DNOW Gears Up to Report Q1 Earnings: What Should You Expect? https://www.zacks.com/stock/news/2270744/dnow-gears-up-to-report-q1-earnings-what-should-you-expect?cid=CS-ZC-FT-analyst_blog|earnings_preview-2270744 May 08, 2024 - DNOW's Q1 results are likely to gain from stronger project activity and an increase in international rig count. However, the higher cost of products is likely to have ailed its performance.
Fidelity National's (FIS) Shares Up 5.5% Since Q1 Earnings Beat https://www.zacks.com/stock/news/2270717/fidelity-national-s-fis-shares-up-5-5-since-q1-earnings-beat?cid=CS-ZC-FT-analyst_blog|earnings_article-2270717 May 08, 2024 - Fidelity National (FIS) revises its adjusted EPS guidance between $4.88 and $4.98, the mid-point of which implies a 46.3% surge from the 2023 figure of $3.37.
Masimo (MASI) Q1 Earnings Beat Estimates, '24 EPS View Up https://www.zacks.com/stock/news/2270706/masimo-masi-q1-earnings-beat-estimates-24-eps-view-up?cid=CS-ZC-FT-analyst_blog|earnings_article-2270706 May 08, 2024 - Masimo's (MASI) Q1 healthcare revenues reflect strong sensor orders, which were completely offset by lower capital equipment purchases. Sensor production in Malaysia is likely to improve Healthcare gross margin.
Autoliv (ALV) Stock Up 7% Since Q1 Earnings & Sales Beat https://www.zacks.com/stock/news/2270690/autoliv-alv-stock-up-7-since-q1-earnings-sales-beat?cid=CS-ZC-FT-analyst_blog|earnings_article-2270690 May 08, 2024 - Autoliv (ALV) forecasts full-year 2024 organic sales growth and adjusted operating margin to be around 5% and 10.5%, respectively.
3 GARP Stocks to Scoop up for Maximum Returns https://www.zacks.com/stock/news/2270781/3-garp-stocks-to-scoop-up-for-maximum-returns?cid=CS-ZC-FT-analyst_blog|rw-2270781 May 08, 2024 - Try the GARP strategy when seeking a profitable portfolio of stocks offering optimum value and growth investing. RMD, BAH and KTB are some stocks that hold promise.
Summer box office bust? This season's movie slate could put up the lowest haul in decades https://www.cnbc.com/2024/05/08/summer-box-office-preview-movie-slate-lacks-franchise-hits.html May 08, 2024 - This summer's box office, hampered by dual Hollywood labor strikes, could have the lowest movie ticket haul since 2000.
QMOM: Midcap Momentum Fund Up +17% This Year https://seekingalpha.com/article/4690497-qmom-midcap-momentum-fund-up-plus-17-percent-this-year?source=feed_tag_etf_portfolio_strategy May 07, 2024 - The Alpha Architect U.S. Quantitative Momentum ETF has outperformed most equity ETFs. Read why we feel conditions do not warrant a Buy rating for QMOM.
CytomX teams up with Merck for CX-801 clinical study https://seekingalpha.com/news/4101861-cytomx-teams-up-with-merck-for-cx-801-clinical-study?source=feed_sector_healthcare May 07, 2024 - CytomX Therapeutics (CTMX) said it is teaming up with Merck (MRK) for a Phase 1 clinical trial of its drug candidate CX-801 in the treatment of various cancers.
Select Medical's (SEM) Shares Up 12.9% Since Q1 Earnings Beat https://www.zacks.com/stock/news/2269942/select-medical-s-sem-shares-up-12-9-since-q1-earnings-beat?cid=CS-ZC-FT-analyst_blog|earnings_article-2269942 May 07, 2024 - Select Medical (SEM) revises its adjusted EBITDA guidance upward between $845 million and $885 million for 2024, the mid-point is higher than $807.4 million in 2023.
<<<Page 127>